Lignocaine HydrochlorideThird Party Manufacturing in India
Looking to get Lignocaine Hydrochloride manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Lignocaine Hydrochloride works by reversibly blocking sensory nerve conduction to prevent pain signals from reaching the central nervous system. It binds selectively to the intracellular portion of voltage-gated sodium channels on the nerve cell membrane. This binding blocks the influx of sodium ions into the neuron, which is necessary for the initiation and propagation of nerve impulses. By preventing depolarization of the nerve membrane, Lignocaine inhibits sensory signal conduction, resulting in localized loss of sensation and pain relief in the target area.
As a topical gel or anesthetic jelly, it provides a swift onset of action within two to five minutes of application. Unlike general anesthetics, Lignocaine Hydrochloride acts locally at the site of administration without affecting patient consciousness. It is highly effective and well-tolerated for a wide range of clinical procedures requiring local mucosal anesthesia, such as urethral catheterization, endoscopy, and minor superficial surgical interventions.
Therapeutic Uses & Indications
Therapeutic Uses
Lignocaine Hydrochloride gel is prescribed and clinically indicated for:
- Local Anesthesia: Provides temporary numbness and pain relief on mucosal membranes before medical examinations or minor surgeries.
- Urethral Anesthesia: Used as a sterile lubricant and anesthetic for catheter insertion and cystoscopy.
- Endoscopic Procedures: Numbs oral or nasal passages during bronchoscopy, gastroscopy, or nasal intubation.
- Skin Irritation and Pain: Relieves pain associated with minor burns, abrasions, insect bites, or hemorrhoids.
Why Manufacturers Choose Lignocaine Hydrochloride
Lignocaine Hydrochloride is one of the most widely used local anesthetics globally, featuring on the WHO Model List of Essential Medicines. This creates a highly stable, high-volume market demand across clinical, hospital, and retail sectors. The gel formulation is an essential product for medical diagnostics and patient comfort during invasive procedures, guaranteeing steady, recurring sales.
For third party manufacturing in India, Lignocaine Hydrochloride represents a technically mature and reliable product line. The formulation of sterile 2% w/v gels requires specialized aseptic manufacturing lines to prevent contamination and maintain stability of the active anesthetic salt. Partnering with WHO-GMP certified facilities ensures strict adherence to quality control and pharmacopoeial standards, facilitating easy exports and smooth domestic distribution. This makes it an ideal formulation for hospital supply contract manufacturing and PCD franchise portfolios.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Lignocaine Hydrochloride?
What dosage forms of Lignocaine Hydrochloride can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Lignocaine Hydrochloride for export?
What grade standards do you follow for Lignocaine Hydrochloride?
Get Lignocaine Hydrochloride made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 5,000 tubes per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Aluminum tube, laminated plastic tube (30g, 50g), sterile pre-filled syringes, or glass vials for injections. Packaging customized to brand guidelines.
Start Manufacturing Lignocaine Hydrochloride Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Lignocaine Hydrochloride across all dosage forms. PCD franchise and export orders welcome.

